Annual report pursuant to Section 13 and 15(d)

Schedule of Capitalized Technology (Details)

v3.23.1
Schedule of Capitalized Technology (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Research and Development [Abstract]    
Balance, beginning of period $ 43,038 $ 25,867
Additional capitalized cost 45,196 49,970
Provision for amortization (23,735) (32,799)
Balance, end of period $ 64,499 $ 43,038